(Q36564936)

15 August 2017

1 reference

title

Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia (English)

1 reference

15 August 2017

0 references

Laura Z Rassenti

1

1 reference

15 August 2017

Thomas J Kipps

series ordinal

2

1 reference

15 August 2017

publication date

1 July 2006

1 reference

Cytometry Part B: Clinical Cytometry

15 August 2017

published in

1 reference

15 August 2017

volume

70

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

209-213

1 reference

Regulation of protein tyrosine kinase activation by the T-cell antigen receptor zeta chain

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

CLL biology and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

Molecular and genetic insights into T cell antigen receptor signal transduction

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

21 January 2018

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

When and how to treat chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Clinical significance of CD38 expression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression does not change in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 modifications in chronic lymphocytic leukemia: are they relevant?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20129

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20129

1 reference

15 August 2017

1 reference